Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ObsEva
Special Reports
The 2024 Biotech Graveyard
Beware: ghosts of biotech’s past.
Gabrielle Masson
Oct 31, 2024 5:00am
ObsEva winds down and lays off staff as money, options run out
Feb 28, 2024 4:51am
ObsEva gets China rights to pregnancy drug over missed deadline
Jul 13, 2023 7:50am
Biogen's Aduhelm architect departs—Chutes & Ladders
Mar 17, 2023 9:30am
ObsEva demolishes US C-suite as Nasdaq delisting looms
Feb 24, 2023 9:45am
ObsEva sells off one of 2 remaining assets to stay afloat
Nov 22, 2022 7:35am
